Theresa Ann Jeary

Title: Theresa Ann Jeary: Innovating Controlled Release Formulations

Introduction: Theresa Ann Jeary is a prominent inventor located in Roscommon, Ireland, recognized for her significant contributions to pharmaceutical formulations. With a passion for innovation, she has developed a unique multiparticulate controlled release formulation aimed at enhancing the delivery of selective serotonin reuptake inhibitors (SSRIs).

Latest Patents: Theresa holds a patent for her invention titled "Multiparticulate controlled release selective serotonin reuptake inhibitor formulations." This groundbreaking formulation features particles of an SSRI or a pharmaceutically acceptable salt, coated with a rate-controlling polymer. This design facilitates a controlled release of the SSRI for extended periods, specifically over 12 hours after oral administration, ensuring more effective therapeutic outcomes.

Career Highlights: Theresa is currently employed at Elan Pharma International Limited, where she has been instrumental in advancing pharmaceutical innovation. Her work focuses on creating formulations that improve the efficacy and safety of medications, particularly in the area of mental health treatment.

Collaborations: Throughout her career, Theresa has collaborated with talented professionals, including her coworkers Catherine Ann Morrissey and Paul Stark. These partnerships have fostered an environment of creativity and mutual support, contributing to the successful development of her innovative formulations.

Conclusion: Theresa Ann Jeary's dedication to innovation in pharmaceutical formulations demonstrates her role as a leading inventor in the field. Her work at Elan Pharma International Limited and her patented SSRI formulation are testaments to her commitment to enhancing patient care through advanced therapeutic solutions. As the pharmaceutical landscape continues to evolve, inventors like Theresa will play a crucial role in shaping the future of medicine.